Literature DB >> 18093236

Genetic diversity of carbapenem-resistant isolates of Acinetobacter baumannii in Europe.

K J Towner1, K Levi, M Vlassiadi.   

Abstract

In total, 96 carbapenem-resistant isolates of Acinetobacter baumannii were obtained from 25 hospitals in 17 European countries. Imipenem MICs ranged from <4 to 128 mg/L on retesting by Etest, with MICs > or =16 mg/L being associated with the carriage of genes encoding at least one other class D carbapenemase in addition to the intrinsic OXA-51-like enzyme. Molecular typing results obtained by random amplified polymorphic DNA analysis, followed by pulsed-field gel electrophoresis (PFGE) of ApaI-digested chromosomal DNA, were highly congruent, with 17 different PFGE types being delineated at a cut-off similarity level of 85%. With few exceptions, multiple isolates from a single hospital belonged to the same PFGE type. Seven sequence groups were identified among the 96 A. baumannii isolates, with the majority of isolates (n = 81) belonging to the previously defined sequence groups 1 and 2, which each included eight PFGE types. These two multinational lineages included the previously defined European clones II and I, respectively, but the problem of resistant A. baumannii in Europe appeared not to be confined solely to these two European clones. Rather, two broader lineages of carbapenem-resistant A. baumannii now seem to be spreading throughout Europe.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18093236     DOI: 10.1111/j.1469-0691.2007.01911.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  29 in total

1.  In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.

Authors:  Paul G Higgins; Thamarai Schneiders; Axel Hamprecht; Harald Seifert
Journal:  Antimicrob Agents Chemother       Date:  2010-10-04       Impact factor: 5.191

2.  Growth in glucose-based medium and exposure to subinhibitory concentrations of imipenem induce biofilm formation in a multidrug-resistant clinical isolate of Acinetobacter baumannii.

Authors:  Elisabetta Nucleo; Laura Steffanoni; Giulia Fugazza; Roberta Migliavacca; Ernesto Giacobone; Antonella Navarra; Laura Pagani; Paolo Landini
Journal:  BMC Microbiol       Date:  2009-12-22       Impact factor: 3.605

3.  Dissemination of a carbapenem-resistant Acinetobacter baumannii strain belonging to international clone II/sequence type 2 and harboring a novel AbaR4-like resistance island in Latvia.

Authors:  Mara Saule; Ørjan Samuelsen; Uga Dumpis; Arnfinn Sundsfjord; Aija Karlsone; Arta Balode; Edvins Miklasevics; Nabil Karah
Journal:  Antimicrob Agents Chemother       Date:  2012-12-10       Impact factor: 5.191

4.  Distribution and Molecular Characterization of Acinetobacter baumannii International Clone II Lineage in Japan.

Authors:  Mari Matsui; Masato Suzuki; Masahiro Suzuki; Jun Yatsuyanagi; Masanori Watahiki; Yoichi Hiraki; Fumio Kawano; Atsuko Tsutsui; Keigo Shibayama; Satowa Suzuki
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

5.  Evidence of diversity among epidemiologically related carbapenemase-producing Acinetobacter baumannii strains belonging to international clonal lineage II.

Authors:  Fabrizia Minandri; Silvia D'Arezzo; Luísa C S Antunes; Christine Pourcel; Luigi Principe; Nicola Petrosillo; Paolo Visca
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

6.  Acinetobacter baumannii Biofilm Formation in Human Serum and Disruption by Gallium.

Authors:  Federica Runci; Carlo Bonchi; Emanuela Frangipani; Daniela Visaggio; Paolo Visca
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

7.  Epidemic diffusion of OXA-23-producing Acinetobacter baumannii isolates in Italy: results of the first cross-sectional countrywide survey.

Authors:  Luigi Principe; Aurora Piazza; Tommaso Giani; Silvia Bracco; Maria Sofia Caltagirone; Fabio Arena; Elisabetta Nucleo; Federica Tammaro; Gian Maria Rossolini; Laura Pagani; Francesco Luzzaro
Journal:  J Clin Microbiol       Date:  2014-06-11       Impact factor: 5.948

8.  Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a tertiary care hospital in Naples, Italy, shows the emergence of a novel epidemic clone.

Authors:  Maria Giannouli; Susanna Cuccurullo; Valeria Crivaro; Anna Di Popolo; Mariano Bernardo; Federica Tomasone; Gerardino Amato; Sylvain Brisse; Maria Triassi; Riccardo Utili; Raffaele Zarrilli
Journal:  J Clin Microbiol       Date:  2010-02-24       Impact factor: 5.948

9.  Occurrence of OXA-107 and ISAba1 in carbapenem-resistant isolates of Acinetobacter baumannii from Croatia.

Authors:  Ivana Goic-Barisic; Branka Bedenic; Marija Tonkic; Anita Novak; Stjepan Katic; Smilja Kalenic; Volga Punda-Polic; Kevin J Towner
Journal:  J Clin Microbiol       Date:  2009-08-19       Impact factor: 5.948

10.  Carbapenem resistance and acquired class D beta-lactamases in Acinetobacter baumannii from Croatia 2009-2010.

Authors:  M Vranić-Ladavac; B Bedenić; F Minandri; M Ištok; Z Bošnjak; S Frančula-Zaninović; R Ladavac; P Visca
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-11-06       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.